Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 May 21;135(21):1829-1832.
doi: 10.1182/blood.2020006028.

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Joachim Yahalom  1 , Bouthaina Shbib Dabaja  2 , Umberto Ricardi  3 , Andrea Ng  4 , N George Mikhaeel  5 , Ivan R Vogelius  6 , Tim Illidge  7 , Shunan Qi  8 , Andrew Wirth  9 , Lena Specht  6
Affiliations
Practice Guideline

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Joachim Yahalom et al. Blood. .

Abstract

The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

References

    1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention [published online ahead of print 24 February 2020]. JAMA. doi:10.1001/jama.2020.2648. - PubMed
    1. Liang W, Guan W, Chen R, et al. . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337. - PMC - PubMed
    1. Constine LS, Yahalom J, Ng AK, et al. . The role of radiation therapy in patients with relapsed or refractory Hodgkin lymphoma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018;100(5):1100-1118. - PubMed
    1. Dabaja BS, Hoppe BS, Plastaras JP, et al. . Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines [published correction appears in Blood. 2019;133(12):1384-1385]. Blood. 2018;132(16):1635-1646. - PMC - PubMed
    1. Dabaja BS, Specht L, Yahalom J. Lymphoblastic lymphoma: guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. 2018;102(3):508-514. - PubMed

Publication types

MeSH terms